Thu, Nov 12, 2026 - Page 59
13819 indexed SquawkNews stories from this UTC day. Showing 6961-7080.
M
Sonova Raises Full-Year Guidance After First-Half Revenue Growth
Revenue rose 6.7% to 1.83 billion Swiss francs in the first half of fiscal 2026/27. Sonova now targets full-year revenue growth of 6–8% and core EBIT growth of 10–13% at constant exchange rates.
EQUITY | Nov 12, 2026, 01:03 PM UTC
H
HUBSPOT - REAFFIRMS Q4 AND FULL YEAR 2026 FINANCIAL GUIDANCE
HUBSPOT - REAFFIRMS Q4 AND FULL YEAR 2026 FINANCIAL GUIDANCE
EARNINGS | Nov 12, 2026, 01:03 PM UTC
L
VulcanForms Financing Led by JPMorgan and Apollo Funds
VulcanForms says financing led by J.P. Morgan and funds managed by Apollo will accelerate the next phase of American industrial production.
EQUITY | Nov 12, 2026, 01:03 PM UTC
L
HubSpot appoints Karen Burgess as CFO effective Feb. 11, 2027
EQUITY | Nov 12, 2026, 01:03 PM UTC
L
Theriva Biologics Q3 2026 Net Loss Narrows 66% to $1.47 Million
Theriva Biologics Q3 2026 Net Loss Narrows 66% to $1.47 Million Theriva Biologics’ third-quarter
EQUITY | Nov 12, 2026, 01:03 PM UTC
L
BRIEF-LiqTech Q3 Revenue USD 4.4 Million
BRIEF-LiqTech Q3 Revenue USD 4.4 Million Nov 12 (Reuters) - LiqTech outlook FY revenue USD 20-23 mil
EARNINGS | Nov 12, 2026, 01:03 PM UTC
L
BRIEF-Imunon Q3 EPS USD -0.64
BRIEF-Imunon Q3 EPS USD -0.64 Nov 12 (Reuters) - Imunon Q3 net income USD -3.75 million. Q3 operatin
EARNINGS | Nov 12, 2026, 01:03 PM UTC
L
NEXTPLAT REPORTS 3Q RESULTS WITH NEARLY 35% IMPROVEMENT IN YEAR-OVER-YEAR GROSS PROFIT, CONSOLIDATED QUARTERLY GROSS MARGINS OF 35% & APPROX
NEXTPLAT REPORTS 3Q RESULTS WITH NEARLY 35% IMPROVEMENT IN YEAR-OVER-YEAR GROSS PROFIT, CONSOLIDATED
EARNINGS | Nov 12, 2026, 01:03 PM UTC
L
BRIEF-Nuwellis Q3 Gross Profit USD 1.538 Million
BRIEF-Nuwellis Q3 Gross Profit USD 1.538 Million Nov 12 (Reuters) - Nuwellis Q3 income from operatio
EARNINGS | Nov 12, 2026, 01:03 PM UTC
L
Cohen & Company Names Daniel G. Cohen CEO, Succeeding Lester Brafman
EQUITY | Nov 12, 2026, 01:03 PM UTC
M
Tonix Pharmaceuticals CEO Acquires $20,275 in Common Shares
Tonix Pharmaceuticals CEO Seth Lederman acquired $20,275 in common shares.
EQUITY | Nov 12, 2026, 01:03 PM UTC
L
Cohen & Company Reports Third Quarter 2026 Financial Results
Cohen & Company Reports Third Quarter 2026 Financial Results PHILADELPHIA and NEW YORK, Nov. 12, 202
EQUITY | Nov 12, 2026, 01:03 PM UTC
L
BRIEF-Theriva Biologics Q3 Net Income USD -1.471 Million
BRIEF-Theriva Biologics Q3 Net Income USD -1.471 Million Nov 12 (Reuters) - Theriva Biologics Q3 inc
FX | Nov 12, 2026, 01:03 PM UTC
L
BRIEF-Ondas Q3 Revenue USD 167.5 Million Vs. IBES Estimate USD 148 Million
BRIEF-Ondas Q3 Revenue USD 167.5 Million Vs. IBES Estimate USD 148 Million Nov 12 (Reuters) - Ondas
EARNINGS | Nov 12, 2026, 01:03 PM UTC
L
AMD Expands PsiQuantum Partnership, Plans Equity Investment
AMD expanded its strategic partnership with PsiQuantum and plans an equity investment.
EQUITY | Nov 12, 2026, 01:02 PM UTC
M
Jury Returns Unanimous Verdict in Favor of Skye Bioscience
A jury returned a unanimous verdict in Skye Bioscience’s favor on Nov. 10 in the Wendy Cunning lawsuit, according to an SEC filing.
REGULATION | Nov 12, 2026, 01:02 PM UTC
L
BRIEF-Imunon Q3 EPS USD -0.64
Nov 12 (Reuters) - Imunon Q3 net income USD -3.75 million.
EARNINGS | Nov 12, 2026, 01:02 PM UTC
L
Cohen & Company Reports Third Quarter 2026 Financial Results
PHILADELPHIA and NEW YORK, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Cohen & Company Inc.
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
MeiraGTx Reports Third Quarter 2026 Financial and Operational Results
Submission of Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for b
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
Artelo Biosciences Provides Business Update and Reports 2026 Third Quarter Financial Results
SOLANA BEACH, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc.
CRYPTO | Nov 12, 2026, 01:02 PM UTC
L
Barndoor AI Gateway Now Available on Google Cloud Marketplace
Enterprises can buy Barndoor through Google Cloud Marketplace to govern MCP tool access.
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
NextPlat Reports 3Q Results with Nearly 35% Improvement in Year-Over-Year Gross Profit, Consolidated Quarterly Gross Margins of 35% & Approx
Company Sees 72% Growth in Higher Margin 340B Prescription Volumes as it Continues to Expand its Pha
EARNINGS | Nov 12, 2026, 01:02 PM UTC
L
Roundhill launches Magnificent Seven Plus ETF
The ETF combines the Magnificent Seven with Anthropic, OpenAI, SpaceX and Broadcom.
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
Avalyn Reports Third Quarter 2026 Financial Results and Recent Business Highlights
Initiated Phase 1 study of AP03, a fixed dose combination of nebulized pirfenidone and nintedanib, i
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
Theriva™ Biologics Reports Third Quarter 2026 Operational Highlights and Financial Results
VIRAGE2 enrollment expected to complete in Q4 2026; initial data expected by Q3 2027 — — Company c
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
AgEagle Aerial Systems Inc. (UAVS) Reports Drone Sales in Seven Countries in One Week
AgEagle Aerial Systems Inc. reported drone sales into seven countries in one week across North America, Latin America, Europe and Africa. It did not disclose order values or a prior-period comparison.Material DetailsCont
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
Vivani Medical Announces Positive Top-Line Results from SLIM-1™, a First in Human Phase 1 Trial of NPM-139 (semaglutide implant) and Wegovy
Strong NPM-139 safety and tolerability profile: -0 of 10 NPM-139 subjects experienced adverse events
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
CITGO Reports Record Third-Quarter 2026 Results
Third Quarter 2026 Highlights Generated net income of $2.2 billion and EBITDA and Adjusted EBITDA1 o
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
LiqTech International Announces Third Quarter 2026 Financial Results
BALLERUP, Denmark, Nov. 12, 2026 (GLOBE NEWSWIRE) -- LiqTech International, Inc.
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
Hyro Achieves Oracle Health Endpoint Validation Expertise
Hyro announced it has achieved Oracle Health Endpoint Validation Expertise.
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
DeFi Development Corp. Reports Strong Q3 2026 Results; NAV per Share More Than Quadruples and SOL per Share Grows Over 20%
BOCA RATON, FL, Nov. 12, 2026 (GLOBE NEWSWIRE) -- DeFi Development Corp.
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
Vasa Therapeutics Announces Positive Topline Results from Randomized, Placebo-Controlled Phase 1c Trial of VS-041 for Treatment of Heart Fai
Significant reduction of NT-proBNP after a 28-day treatment with VS-041, a novel therapeutic that ta
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
Leatt Corporation Announces Results for the Third Quarter 2026
Global revenues increase 43% to $20.46 million, highest quarterly revenues in four years; Net income
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
Aktis Oncology Reports Third-Quarter Financial Results and Highlights Clinical Trial Progress
Initiated the Company’s third Phase 1b clinical trial, BActinium-2, broadening the evaluation of AKY
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
Samsonite Group S.A. Announces Results for the Third Quarter and Nine Months Ended September 30, 2026
Third Quarter 2026 Highlights Returned to positive constant currency(1) net sales growth in Q3, up 0
FX | Nov 12, 2026, 01:02 PM UTC
L
RBI Approves Rangan’s Reappointment as HDFC Bank Executive Director for One Year
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
IMUNON, Inc. (IMNN) Reports Q3 Loss of $3.8M, Versus $3.4M a Year Earlier
IMUNON reported Q3 2026 net loss of $3.8M ($0.64 per share), versus $3.4M ($1.16 per share) in Q3 2025. At September 30, cash and cash equivalents were $4.0M, plus $5.0M of restricted cash.Material DetailsContext by AI A
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
Kraft Heinz Expects Organic Sales Growth in Second Half of 2027
Kraft Heinz shared initial expectations for a return to organic net sales growth in the second half of 2027 and margin expansion in 2028.
EARNINGS | Nov 12, 2026, 01:02 PM UTC
L
Lucid Diagnostics Provides Business Update and Reports Third Quarter 2026 Financial Results
EsoGuard® now fully reimbursed by Medicare nationwide, launching a new phase of accelerating commerc
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
BioAdaptives Says Xycota Acquisition Has Not Closed
BioAdaptives said its definitive agreement to acquire Xycota Biosciences, announced October 29, 2026, remains subject to closing conditions and has not closed. No transaction value was provided.
MNA | Nov 12, 2026, 01:02 PM UTC
L
BTCS Reports Record Gross Profit of $3.5 Million and 86% Gross Margin for Third Quarter 2026
WAYNE, Pa., Nov. 12, 2026 (GLOBE NEWSWIRE) -- BTCS Inc.
EARNINGS | Nov 12, 2026, 01:02 PM UTC
L
Aktis Oncology (AKTS) Reports Q3 Results and Advances Three Clinical Trials
Aktis Oncology reported third-quarter 2026 financial results and business updates, including initiation of the BActinium-2 trial and progress across three U.S. clinical trials. The release provides no financial figures.M
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
Arctera Announces Model Context Protocol for Microsoft Copilot Workflows
Arctera announced a new Model Context Protocol, with governance controls, for bringing business information into Microsoft Copilot workflows.
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
European Consumption May Slow as Winter Bites
A live-markets post forecasts slower European consumption as winter sets in.
MACRO | Nov 12, 2026, 01:02 PM UTC
L
NuRAN Wireless Inc. (NUR) Reports 126% Network Revenue Growth and 5,092 Contracted Towers
NuRAN says network-generated revenue increased 126.44% over the preceding 12-month period; average monthly revenue was $1,356 per operational tower. About 300 of 5,092 contracted towers are operational; future deployment
EARNINGS | Nov 12, 2026, 01:02 PM UTC
L
President’s Choice Introduces Bookable Holiday Window Experience in Toronto
President’s Choice is promoting a free immersive dining experience in Yorkville, Toronto, presented as a bookable holiday window.
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
BRIEF-Nuwellis Q3 Gross Profit USD 1.538 Million
Nov 12 (Reuters) - Nuwellis Q3 income from operations USD -2.053 million.
EARNINGS | Nov 12, 2026, 01:02 PM UTC
H
LiveOne (LVO) H1 Revenue Falls 2% To $37.3M; Adjusted EBITDA $3.6M
LiveOne reported H1 fiscal 2027 revenue of $37.3M versus $38.0M a year earlier and Adjusted EBITDA of $3.6M versus a $2.8M loss. Q2 revenue was $18.0M versus $18.8M; Q2 Adjusted EBITDA was a $0.7M loss versus a $1.0M los
EARNINGS | Nov 12, 2026, 01:02 PM UTC
L
CITGO REPORTS RECORD THIRD-QUARTER 2026 RESULTS
CITGO REPORTS RECORD THIRD-QUARTER 2026 RESULTS
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
Vivani Medical Announces Positive Top-Line Results from SLIM-1™, a First in Human Phase 1 Trial of NPM-139 (semaglutide implant) and Wegovy
Strong NPM-139 safety and tolerability profile:-0 of 10 NPM-139 subjects experienced adverse events reported as treatment related-5 of 10 Wegovy subjects (control group) experienced adverse events reported as treatment r
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
Artelo Biosciences Provides Business Update and Reports 2026 Third Quarter Financial Results
Continued Progress Across Pipeline Supports Expanded Therapeutic OpportunitiesSOLANA BEACH, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. NASDAQ:ARTL (“Artelo” or the “Company”), a clinical stage pha
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
Kyverna Therapeutics Announces Completion of BLA Submission for Miv-cel in Stiff Person Syndrome and Reports Third Quarter 2026 Financial Re
BLA submission for miv-cel in SPS completed with request for priority review Commercial readiness ad
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
Theriva™ Biologics Reports Third Quarter 2026 Operational Highlights and Financial Results
VIRAGE2 enrollment expected to complete in Q4 2026; initial data expected by Q3 2027 —— Company completes sale of SYN-004 (ribaxamase) and related portfolio of antibiotic-degrading enzymes to Biossil Labs Inc. in October
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
Aktis Oncology Reports Third-Quarter Financial Results and Highlights Clinical Trial Progress
BOSTON, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. NASDAQ:AKTS (“Aktis” or the “Company”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
PodcastOne, Inc. (PODC) Reports 1H Revenue of $31.5M, Up 4.6% YoY
PodcastOne reported 1H fiscal 2027 revenue of $31.5M, up from $30.2M a year earlier, and Adjusted EBITDA of $3.0M versus $1.7M. Net loss was $2.0M, compared with $2.0M.Material DetailsContext by AI AnalystThis is a mid-c
EARNINGS | Nov 12, 2026, 01:02 PM UTC
L
Erie Strategic Ventures Invests in Blitzy and HiddenLayer
Erie Insurance's corporate venture capital arm added two AI-focused startups to its portfolio.
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
Kyverna Therapeutics Announces Completion of BLA Submission for Miv-cel in Stiff Person Syndrome and Reports Third Quarter 2026 Financial Re
BLA submission for miv-cel in SPS completed with request for priority reviewCommercial readiness advancing for potential U.S. launch of miv-cel, which would become the first approved therapy for SPS and first approved CA
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
Monopar Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates
WILMETTE, Ill., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) NASDAQ:MNPR, a clinical—stage biopharmaceutical company developing innovative treatments for patients with unmet me
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
Grace Therapeutics Announces Second Quarter 2027 Financial Results, Provides Business Update
PRINCETON, N.J., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc.
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
Bloomia Holdings, Inc. (TULP) Q1 Revenue Falls 4%; Adjusted EBITDA Loss Narrows
Q1 revenue was $5.0M versus $5.2M a year earlier; adjusted EBITDA loss narrowed to $1.9M from $2.4M. Net loss attributable to Bloomia Holdings was $2.4M versus $2.9M.Material DetailsContext by AI AnalystThis is an early-
EARNINGS | Nov 12, 2026, 01:02 PM UTC
L
GameSquare Holdings, Inc. (GAME) Expects Seven-Figure Q4 Revenue From Peaky Blinders Initiative
GameSquare expects its Peaky Blinders initiative to contribute seven figures of high-margin revenue in Q4 2026 and a materially larger contribution to annual revenue and profitability in 2027. The Peaky Blinders Pass is
EARNINGS | Nov 12, 2026, 01:02 PM UTC
L
BRIEF-Ondas Q3 Revenue USD 167.5 Million Vs. IBES Estimate USD 148 Million
Nov 12 (Reuters) - Ondas Q3 gross profit USD 36.5 million.
EARNINGS | Nov 12, 2026, 01:02 PM UTC
L
BRIEF-Theriva Biologics Q3 Net Income USD -1.471 Million
Nov 12 (Reuters) - Theriva Biologics Q3 income from operations USD -1.535 million.
FX | Nov 12, 2026, 01:02 PM UTC
L
Nuwellis Reports Third Quarter 2026 Financial Results and Business Update Highlighted by 430 Basis Point Gross Margin Expansion and 13% Redu
Console unit sales increased 88% year-to-date versus prior-year period, expanding its installed base
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
MEIRAGTX REPORTS THIRD QUARTER 2026 FINANCIAL AND OPERATIONAL RESULTS
MEIRAGTX REPORTS THIRD QUARTER 2026 FINANCIAL AND OPERATIONAL RESULTS
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
SAMSONITE GROUP S.A. ANNOUNCES RESULTS FOR THE THIRD QUARTER AND NINE MONTHS ENDED SEPTEMBER 30, 2026
SAMSONITE GROUP S.A. ANNOUNCES RESULTS FOR THE THIRD QUARTER AND NINE MONTHS ENDED SEPTEMBER 30, 202
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
Barclays sets Dorman Products price target at $165 per share
Barclays announced a $165-per-share price target for Dorman Products.
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
BTCS INC. Q3 EPS USD 1.1
BTCS INC. Q3 EPS USD 1.1
EARNINGS | Nov 12, 2026, 01:02 PM UTC
L
THERIVA™ BIOLOGICS REPORTS THIRD QUARTER 2026 OPERATIONAL HIGHLIGHTS AND FINANCIAL RESULTS
THERIVA™ BIOLOGICS REPORTS THIRD QUARTER 2026 OPERATIONAL HIGHLIGHTS AND FINANCIAL RESULTS
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
NUWELLIS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND BUSINESS UPDATE HIGHLIGHTED BY 430 BASIS POINT GROSS MARGIN EXPANSION AND 13% REDU
NUWELLIS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND BUSINESS UPDATE HIGHLIGHTED BY 430 BASIS P
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
LEATT Q3 REVENUE USD 20.46 MILLION
LEATT Q3 REVENUE USD 20.46 MILLION
EARNINGS | Nov 12, 2026, 01:02 PM UTC
L
IMUNON Reports Third Quarter 2026 Financial Results and Provides Business Update
IMNN-001 is the first frontline treatment candidate to demonstrate the potential for a clinically meaningful overall survival benefit in women newly diagnosed with ovarian cancerEnrollment in the Phase 3 OVATION 3 Study
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
MEIRAGTX Q3 INCOME FROM OPERATIONS USD -49.878 MILLION
MEIRAGTX Q3 INCOME FROM OPERATIONS USD -49.878 MILLION
FX | Nov 12, 2026, 01:02 PM UTC
L
LEATT CORPORATION ANNOUNCES RESULTS FOR THE THIRD QUARTER 2026
LEATT CORPORATION ANNOUNCES RESULTS FOR THE THIRD QUARTER 2026
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
Rio2 Names Two Directors and Audit Committee Chair
Rio2 appointed Deborah Starkman as an independent director and audit committee chair, and Maria Sanz as an independent director. Ram Ramachandran and Sidney Robinson retired effective November 11, 2026. The company also
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
LIQTECH Q3 REVENUE USD 4.4 MILLION
LIQTECH Q3 REVENUE USD 4.4 MILLION
EARNINGS | Nov 12, 2026, 01:02 PM UTC
L
BTCS REPORTS RECORD GROSS PROFIT OF $3.5 MILLION AND 86% GROSS MARGIN FOR THIRD QUARTER 2026
BTCS REPORTS RECORD GROSS PROFIT OF $3.5 MILLION AND 86% GROSS MARGIN FOR THIRD QUARTER 2026
EARNINGS | Nov 12, 2026, 01:02 PM UTC
L
LIQTECH OUTLOOK FY REVENUE USD 20-23 MILLION
LIQTECH OUTLOOK FY REVENUE USD 20-23 MILLION
EARNINGS | Nov 12, 2026, 01:02 PM UTC
L
Romania’s Central Bank Cites Risks From Middle East Conflict, Fiscal Correction
CENTRAL_BANK | Nov 12, 2026, 01:02 PM UTC
L
LEATT Q3 GROSS PROFIT USD 9.32 MILLION
LEATT Q3 GROSS PROFIT USD 9.32 MILLION
EARNINGS | Nov 12, 2026, 01:02 PM UTC
L
AI Summit New York Announces Keynote and Featured Speakers
The event says leaders from Google, L’Oréal and Dell Technologies will speak at the Dec. 9–10 summit at the Javits Center.
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
Lam Research Partners With LEGO Education on STEM Learning
The Lam Foundation commits $15 million to support LEGO Education computer science and AI experiences for children. Lam Research was named a founding sponsor of LEGO League.
EQUITY | Nov 12, 2026, 01:02 PM UTC
H
Russia Pres Putin: That Today He Would Discuss, Among Other Things, Territorial Issue With US Envoys — Tass
Russia Pres Putin: That Today He Would Discuss, Among Other Things, Territorial Issue With US Envoys — Tass
GEOPOLITICS | Nov 12, 2026, 01:02 PM UTC
L
GameSquare Announces Peaky Blinders Digital Fan Experience
The planned rollout includes digital collectibles and interactive fan experiences, with expanded gaming, content, merchandising and brand activations. GameSquare expects the initiative to contribute seven figures of high
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
THERIVA BIOLOGICS Q3 NET INCOME USD -1.471 MILLION
THERIVA BIOLOGICS Q3 NET INCOME USD -1.471 MILLION
FX | Nov 12, 2026, 01:02 PM UTC
L
BTCS INC. Q3 NET INCOME USD 54.5 MILLION
BTCS INC. Q3 NET INCOME USD 54.5 MILLION
FX | Nov 12, 2026, 01:02 PM UTC
L
LIQTECH INTERNATIONAL ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS
LIQTECH INTERNATIONAL ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
LiveOne (NASDAQ:LVO) Reports H1 Fiscal 2027 Revenue of $37.3M and Audio Division Revenue of $36.3M with Over $7.8M Adjusted EBITDA*
LOS ANGELES, CA / / November 12, 2026 / LiveOne (NASDAQ:LVO), an award-winning, creator-first music, entertainment, and technology platform, announced today its financial results for the second quarter ("Q2 Fiscal 2027")
EARNINGS | Nov 12, 2026, 01:02 PM UTC
L
PodcastOne (NASDAQ:PODC) Reports Record 1H & Q2 Fiscal 2027 Financial Results; 1H Fiscal 2027 Revenue of $31.5M and Adjusted EBITDA* of $2.9
LOS ANGELES, CA / / November 12, 2026 / PodcastOne (NASDAQ:PODC), a leading publisher and podcast sales network, today announced its record financial results for the second fiscal quarter ("Q2 Fiscal 2027") and first six
EARNINGS | Nov 12, 2026, 01:02 PM UTC
L
Accelerant Announces Third Quarter 2026 Results
Third Quarter 2026 Results Exchange Written Premium of $1.33 billion grew 27% year-over-year Third-P
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
Erie Indemnity Invests in AI Startups Blitzy and HiddenLayer
Erie Strategic Ventures announced investments in AI infrastructure startups Blitzy and HiddenLayer. The release did not disclose investment amounts.
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
TelyRx Appoints Co-Founder Benjamin Atkins Interim CEO and President
TelyRx says its board appointed co-founder Benjamin Atkins as interim chief executive officer and president.
EQUITY | Nov 12, 2026, 01:02 PM UTC
L
Bloomia Holdings, Inc. Announces September 30, 2026 Financial Results
MINNEAPOLIS, MN / / November 12, 2026 / Bloomia Holdings, Inc. NASDAQ:TULP ("Bloomia Holdings" or the "Company") today announced its financial results for the first fiscal quarter ended September 30, 2026.The Company rep
EQUITY | Nov 12, 2026, 01:01 PM UTC
L
Ross Names Bank of America Official Bank of CityPlace
EQUITY | Nov 12, 2026, 01:01 PM UTC
L
THERIVA BIOLOGICS Q3 PRETAX PROFIT USD -1.471 MILLION
THERIVA BIOLOGICS Q3 PRETAX PROFIT USD -1.471 MILLION
EARNINGS | Nov 12, 2026, 01:01 PM UTC
L
AVALYN REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS
AVALYN REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS
EQUITY | Nov 12, 2026, 01:01 PM UTC
L
Mobix Labs Says 4Q Rev More Than Doubles and Fighter-Jet Orders Climb
Mobix Labs Says 4Q Rev More Than Doubles and Fighter-Jet Orders Climb
EQUITY | Nov 12, 2026, 01:01 PM UTC
L
ONDAS Q3 REVENUE USD 167.5 MILLION VS. IBES ESTIMATE USD 148 MILLION
ONDAS Q3 REVENUE USD 167.5 MILLION VS. IBES ESTIMATE USD 148 MILLION
EARNINGS | Nov 12, 2026, 01:01 PM UTC
L
Nuwellis 3Q Sales $2.21M >NUWE
Nuwellis 3Q Sales $2.21M >NUWE
EQUITY | Nov 12, 2026, 01:01 PM UTC
L
Nuwellis 3Q Loss $2M >NUWE
Nuwellis 3Q Loss $2M >NUWE
EQUITY | Nov 12, 2026, 01:01 PM UTC
M
NextPlat Reports 35% Gross Margin and 66% Lower Q3 Net Loss
NextPlat reported approximately 35% consolidated gross margins and an approximately 66% year-over-year reduction in net loss for Q3 2026. Gross profit improved nearly 35% year over year, while 340B prescription volumes g
EQUITY | Nov 12, 2026, 01:01 PM UTC
L
MEIRAGTX Q3 NET INCOME USD -51.281 MILLION
MEIRAGTX Q3 NET INCOME USD -51.281 MILLION
FX | Nov 12, 2026, 01:01 PM UTC
L
NUWELLIS Q3 SALES USD 2.212 MILLION
NUWELLIS Q3 SALES USD 2.212 MILLION
FX | Nov 12, 2026, 01:01 PM UTC
L
Erie Strategic Ventures Invests in Blitzy and HiddenLayer
Erie Strategic Ventures invested in Blitzy and HiddenLayer.
EQUITY | Nov 12, 2026, 01:01 PM UTC
L
NUWELLIS Q3 NET INCOME USD -1.969 MILLION
NUWELLIS Q3 NET INCOME USD -1.969 MILLION
FX | Nov 12, 2026, 01:01 PM UTC
L
KYVERNA THERAPEUTICS ANNOUNCES COMPLETION OF BLA SUBMISSION FOR MIV-CEL IN STIFF PERSON SYNDROME AND REPORTS THIRD QUARTER 2026 FINANCIAL RE
KYVERNA THERAPEUTICS ANNOUNCES COMPLETION OF BLA SUBMISSION FOR MIV-CEL IN STIFF PERSON SYNDROME AND
EQUITY | Nov 12, 2026, 01:01 PM UTC
L
THERIVA BIOLOGICS Q3 INCOME FROM OPERATIONS USD -1.535 MILLION
THERIVA BIOLOGICS Q3 INCOME FROM OPERATIONS USD -1.535 MILLION
FX | Nov 12, 2026, 01:01 PM UTC
L
IMUNON Reports Third Quarter 2026 Financial Results and Provides Business Update
IMNN-001 is the first frontline treatment candidate to demonstrate the potential for a clinically me
EQUITY | Nov 12, 2026, 01:01 PM UTC
L
Lymphoma Research Foundation to Honor Research, Advocacy and Philanthropy Leaders at Gala
Dr. Peter Martin, AbbVie and the Werner Family will be recognized at the foundation’s November 13 event in New York City.
MACRO | Nov 12, 2026, 01:01 PM UTC
L
AMD and PsiQuantum Explore Expanding Collaboration in Chicago
The companies are exploring an expanded collaboration at the Illinois Quantum and Microelectronics Park.
EQUITY | Nov 12, 2026, 01:01 PM UTC
L
MeiraGTx Holdings 3Q Rev $4.81M >MGTX
MeiraGTx Holdings 3Q Rev $4.81M >MGTX
EQUITY | Nov 12, 2026, 01:01 PM UTC
L
Kyverna Therapeutics Announces Completion of BLA Submission for Miv-cel in Stiff Person Syndrome and Reports Third Quarter 2026 Financial Re
Kyverna Therapeutics Announces Completion of BLA Submission for Miv-cel in Stiff Person Syndrome and
EQUITY | Nov 12, 2026, 01:01 PM UTC
L
ACCELERANT HOLDINGS Q3 NET INCOME USD -9.2 MILLION
ACCELERANT HOLDINGS Q3 NET INCOME USD -9.2 MILLION
FX | Nov 12, 2026, 01:01 PM UTC
L
ACCELERANT HOLDINGS Q3 PRETAX PROFIT USD -1.6 MILLION
ACCELERANT HOLDINGS Q3 PRETAX PROFIT USD -1.6 MILLION
EARNINGS | Nov 12, 2026, 01:01 PM UTC
M
HubSpot Names Brian Halligan CEO in Leadership Transition
Co-founder Brian Halligan returns as CEO. Yamini Rangan will step down as CEO and leave the board; CFO Karen Burgess will succeed Kate Bueker, who plans to retire in February 2027.
EQUITY | Nov 12, 2026, 01:01 PM UTC
L
PsiQuantum and AMD Expand Collaboration on Quantum Computing
The collaboration brings together AMD CPUs, GPUs, adaptive computing and software with PsiQuantum’s quantum-computing effort.
EQUITY | Nov 12, 2026, 01:01 PM UTC
L
NUWELLIS Q3 INCOME FROM OPERATIONS USD -2.053 MILLION
NUWELLIS Q3 INCOME FROM OPERATIONS USD -2.053 MILLION
FX | Nov 12, 2026, 01:01 PM UTC
L
Related Ross Names Bank of America Official Bank of CityPlace
Related Ross named Bank of America the official bank of CityPlace in West Palm Beach.
EQUITY | Nov 12, 2026, 01:01 PM UTC
L
NextPlat Reports 3Q Results with Nearly 35% Improvement in Year-Over-Year Gross Profit, Consolidated Quarterly Gross Margins of 35% & Approx
Company Sees 72% Growth in Higher Margin 340B Prescription Volumes as it Continues to Expand its Pharmacy FootprintHALLANDALE BEACH, Fla., Nov. 12, 2026 // -- NextPlat Corp (NASDAQ:NXPL) ("NextPlat" or the "Company"), a
EARNINGS | Nov 12, 2026, 01:01 PM UTC
L
Viatris Named to Fortune’s World’s Best Workplaces List for Second Year
Viatris said it was named to Fortune’s World’s Best Workplaces list for the second consecutive year.
EQUITY | Nov 12, 2026, 01:01 PM UTC